The Secretary may make the following additional clinical guidance available on the Department's website:
A. Any available opioid overdose reversal drug formulations, corresponding prescribing templates, and any standing order for these drugs; and
B. Any other applicable information deemed necessary by the Secretary.
Md. Code Regs. 10.13.03.04
Regulation .04 adopted effective 46:12 Md. R. 541, eff. 6/17/2019